Literature DB >> 6123720

Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus.

G C Viberti, R D Hill, R J Jarrett, A Argyropoulos, U Mahmud, H Keen.   

Abstract

The overnight urinary albumin excretion rate (AER) of 87 patients with insulin-dependent diabetes mellitus was measured in 1966-67, 14 years later information was obtained on 63 of the original cohort; those alive were restudied, and for those who had died relevant clinical information and case of death were recorded. The development of clinical diabetic nephropathy ('Albustix'positive proteinuria) was related to the 1966-67 AER values. Clinical proteinuria developed in only 2 of 55 patients with AER below 30 microgram/min but in 7 of 8 with AER between 30 and 140 microgram/min. The risk of clinical diabetic nephropathy in the latter group was twenty-four time higher than inthe former. 9.1% of patients with AER below 30 microgram/min had died, compared with 37.5% with higher AER. The two groups did not differ significantly in age, sex composition, and initial blood pressure. Mean duration of diabetes was longer, but not significantly so, in those with AER above 30 microgram/min. Thus, elevated levels of microalbuminuria strongly predict the development of clinical diabetic nephropathy. These levels of AER are potentially reversible, and their detection and treatment may prevent diabetic renal disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6123720     DOI: 10.1016/s0140-6736(82)92450-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  333 in total

Review 1.  Is it possible to predict diabetic kidney disease?

Authors:  S M Thomas; G C Viberti
Journal:  J Endocrinol Invest       Date:  2000-01       Impact factor: 4.256

Review 2.  Management of diabetic nephropathy.

Authors:  L Foggensteiner; S Mulroy; J Firth
Journal:  J R Soc Med       Date:  2001-05       Impact factor: 5.344

3.  Occurrence of microalbuminuria in young people with Type 1 diabetes: importance of age and diabetes duration.

Authors:  C R Alleyn; L K Volkening; J Wolfson; A Rodriguez-Ventura; J R Wood; L M B Laffel
Journal:  Diabet Med       Date:  2010-05       Impact factor: 4.359

Review 4.  Risk predictors in patients with diabetic nephropathy.

Authors:  P Fioretto; M L Caramori; M Dalla Vestra; M Mauer
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

Review 5.  Circadian changes in blood pressure and their relationships to the development of microalbuminuria in type 1 diabetic patients.

Authors:  Donn Hogan; Empar Lurbe; M Reza Salabat; Josep Redon; Daniel Batlle
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

Review 6.  The relationship between glucose control and the development and progression of diabetic nephropathy.

Authors:  Carrie A Phillips; Mark E Molitch
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

7.  Increased cholesterylester transfer activity in complicated type 1 (insulin-dependent) diabetes mellitus--its relationship with serum lipids.

Authors:  R P Dullaart; J E Groener; L D Dikkeschei; D W Erkelens; H Doorenbos
Journal:  Diabetologia       Date:  1989-01       Impact factor: 10.122

8.  Retinopathy is associated with higher glycaemia in maturity-onset type diabetes.

Authors:  J Howard-Williams; R M Hillson; A Bron; P Awdry; J I Mann; T D Hockaday
Journal:  Diabetologia       Date:  1984-08       Impact factor: 10.122

9.  Increased vasopressor responsiveness to angiotensin II in type 1 (insulin-dependent) diabetic patients without complications.

Authors:  P L Drury; G M Smith; J B Ferriss
Journal:  Diabetologia       Date:  1984-08       Impact factor: 10.122

10.  Development and progression of microalbuminuria in a clinic sample of patients with insulin dependent diabetes mellitus.

Authors:  C A Jones; G P Leese; S Kerr; K Bestwick; D I Isherwood; J P Vora; D A Hughes; C Smith
Journal:  Arch Dis Child       Date:  1998-06       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.